Publications
20
Citations
517
Est. group size
~5
Recurring co-author estimate
Active years
10
Publishing since 2017
Bufan Xiao's work centers on cancer biology and emerging cell- and gene-based therapies, particularly in lung and nasopharyngeal cancers. Recent publications explore CAR-T cell engineering for solid tumors, molecular markers (microRNAs, long non-coding RNAs, and gene expression signatures) linked to cancer progression and prognosis, and applications of AI and machine learning in cancer diagnosis and treatment planning. This research combines laboratory-based molecular cancer studies with translational and clinical applications, including surgical support tools and therapy evaluation.
Publication output has been variable over the last decade, with a peak in 2018, a gap in 2020, and a modest resurgence in recent years averaging just over two papers per year.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- MMP3 overexpression enhances CAR-T cell infiltration and antitumor activity in a CAF-enriched solid tumor model
Journal for ImmunoTherapy of Cancer · 2026
- Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance
International Journal of Molecular Sciences · 2025
- Visualizing the multi-level assembly structures of conjugated molecular systems with chain-length dependent behavior
Nature Communications · 2023
- Visualizing the multi-level assembly structures of conjugated molecular systems with chain-length dependent behavior
Figshare · 2023
- Accuracy and efficiency of an artificial intelligence-based pulmonary broncho-vascular three-dimensional reconstruction system supporting thoracic surgery: retrospective and prospective validation study
EBioMedicine · 2022
- circ_0000567/miR-421/<i>TMEM100</i> Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis
Journal of Cancer · 2022
- Accuracy and Efficiency of a Novel Artificial Intelligence-Based Pulmonary Broncho-Vascular Three-Dimensional Reconstruction System Supporting Thoracic Surgery: Retrospective and Prospective Validation Study
SSRN Electronic Journal · 2022
- Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges
Frontiers in Immunology · 2021
- Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
Frontiers in Oncology · 2021
- Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma
Medical Science Monitor · 2019
- The decade of exosomal long RNA species: an emerging cancer antagonist
Molecular Cancer · 2018
- The Prognostic Value of Expression of the Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) in Patients with Solid Malignant Tumors: A Systematic Review and Meta-Analysis
Medical Science Monitor · 2018
- NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma.
PubMed · 2018
- Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled Trials
Kidney International Reports · 2018
- miR-24-3p promotes cell migration and invasion by targeting TEL2 in nasopharyngeal carcinoma
Translational Cancer Research · 2018
- Medical Science Monitor×2
- Zenodo (CERN European Organization for Nuclear Research)×2
- Molecular Cancer×1
- Frontiers in Immunology×1
- Nature Communications×1
- Shihyoung Kim
Medicine · The Ohio State University
- Audrey M. Sigmund
Medicine · The Ohio State University
- Alexander W. Rankin
Medicine · The Ohio State University
- Alma Habib
Medicine · The Ohio State University
- Ananda Kumar Kanduluru
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile